Noel Hall
Angel Investor
Noel Hall is a seed investor focused on Biotechnology and SaaS. Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Noel Hall invests in
Stages Noel Hall invests in
Countries Noel Hall invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.5M–$5.5M
Investment Focus
Industry
- Biotechnology 2 (67%)
- SaaS 1 (33%)
- Genetics 1 (33%)
- Biopharma 1 (33%)
- Health Care 1 (33%)
Stage
- Seed 2 (67%)
- Angel 1 (33%)
Country
- Canada 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform. | $2.5M / Seed / Jul 12, 2021 | ||
| At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us. | $5.5M / Seed / Apr 06, 2021 | ||
| IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform. | $376K / Angel / Sep 22, 2020 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Noel Hall invest in?
Noel Hall invests primarily in Biotechnology, SaaS and Genetics startups, most often at Seed and Angel stage. Most of the 3 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Noel Hall invest in?
Noel Hall typically joins rounds of $2.5M–$5.5M at Seed. These are whole funding-round sizes, not Noel Hall's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Noel Hall took part in.
How do I contact Noel Hall?
Public channels for Noel Hall include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Noel Hall last invest?
The most recent investment recorded for Noel Hall closed in Jul 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
